Gufic Biosciences (BOM:509079) Total Equity: ₹6,650 Mil (As of Mar. 2026)


BOM:509079 Gufic Biosciences Ltd BOM:509079
76 GF Score
Price ₹391.85
GF Value ₹408.68
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Gufic Biosciences Total Equity?

Gufic Biosciences BOM:509079 +1.23% 76 Total Equity is ₹6,650 Mil as of Mar. 2026. GuruFocus rates BOM:509079 with a GF Score™ of 76/100 and a GF Value™ of ₹408.68 (Fairly Valued). The stock has 7 warning signs investors should review.

Gufic Biosciences's total equity for the quarter that ended in Mar. 2026 was ₹6,650 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Gufic Biosciences Total Equity Historical Data

* Premium members only.

The historical data trend for Gufic Biosciences's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gufic Biosciences Total Equity Chart

Gufic Biosciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,691.18 3,478.08 5,325.61 6,010.77 6,649.87

Gufic Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6,010.77 0.00 6,311.64 0.00 6,649.87
BOM:509079
76GF Score
Gufic Biosciences Ltd BOM:509079
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gufic Biosciences Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Gufic Biosciences's Total Equity for the fiscal year that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=13423.74-6773.873
=6,650

Gufic Biosciences's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=13423.74-6773.873
=6,650

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of ₹6,650 Mil mean?
Gufic Biosciences (BOM:509079) has a Total Equity of ₹6,650 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Gufic Biosciences and its competitors.
Is Gufic Biosciences' Total Equity too high?
Gufic Biosciences' current Total Equity is ₹6,650 Mil. Overall, Gufic Biosciences has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Gufic Biosciences' Total Equity compare to ZTS and UTHR?
Gufic Biosciences' Total Equity of ₹6,650 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Drug Manufacturers company?
A good Total Equity depends on the Drug Manufacturers industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Gufic Biosciences and its competitors. Gufic Biosciences's current Total Equity is ₹6,650 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gufic Biosciences stock overvalued right now?
Based on GuruFocus' analysis, Gufic Biosciences (BOM:509079) is currently considered Fairly Valued. The stock's GF Value™ is ₹408.68, compared to a current price of ₹391.85 — trading 4.1% below its estimated fair value. The current Total Equity is ₹6,650 Mil. Gufic Biosciences' overall GF Score™ is 76/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Gufic Biosciences (BOM:509079), the current Total Equity is ₹6,650 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gufic Biosciences (BOM:509079) Overvalued in 2026?

Based on GuruFocus' analysis, Gufic Biosciences stock appears to be undervalued. The current stock price of ₹391.85 is trading 4.1% below its estimated GF Value™ of ₹408.68. GuruFocus considers Gufic Biosciences to be Fairly Valued.

Key valuation signals for BOM:509079:

  • Total Equity: ₹6,650 Mil
  • GF Value™: ₹408.68 vs. price of ₹391.85 (4.1% below fair value)
  • GF Score™: 76/100 with 7 warning signs

No single metric tells the full story. See the BOM:509079 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gufic Biosciences Business Description

Other Exchanges GUFICBIO:India
Address SM House, 11 Sahakar Road, 1st to 4th Floor, Vile Parle (East), Mumbai, MH, IND, 400 057
Gufic Biosciences Ltd is engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals, and related services. Geographically, it derives a majority of revenue from India. Its product portfolio includes Criticare, Criticare Life, Ferticare, Spark, Herbal, and other products. The company's lyophilized product includes antibiotics, anti-fungal, cardiac, infertility, anti-viral, and a proton-pump inhibitor. It derives maximum revenue from India.
76GF Score

Get the complete analysis for BOM:509079

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹391.85
Price
₹408.68
GF Value